G1 Therapeutics(GTHX) - 2023 Q3 - Earnings Call Transcript

With that, I'll turn the call over to Andrew. The mechanism of action of trilaciclib impacts longer-term endpoints like overall survival to a greater extent than shorter-term endpoints. Preserving bone marrow and immune system function, in addition to enhancing anti-tumor immunity should allow patients to benefit while receiving trilaciclib and also while receiving subsequent anti-cancer therapies following trilaciclib. Company Participants Thank you, Teresa. Good morning, everyone, and welcome to the G1 co ...